ENDEFR
Home › Germany › Medac Gesellschaft für klinische Spezialpräparate m.b.H.

Medac Gesellschaft für klinische Spezialpräparate m.b.H.

Gesellschaft mit beschränkter Haftung (GmbH) · Wedel, Germany · LEI 529900CYHUGUOZJN0I17
LEI activegroup parent

Summary

Medac Gesellschaft für klinische Spezialpräparate m.b.H. is registered in Germany and entered in the “Commercial Register (Handelsregister)” under number HRB 12042 PI. Its legal form is Gesellschaft mit beschränkter Haftung (GmbH) – private limited company (Germany). Medac Gesellschaft für klinische Spezialpräparate m.b.H. is the ultimate parent of a group of 1 subsidiary in 2 countries, as reported to GLEIF. GLEIF gives this reason: no known person controls the entity, for example because its shareholders are diverse. It has 1 direct subsidiary in GLEIF data. The LEI was first issued on 4 Feb 2014 and the record was last updated on 7 Dec 2025; the next renewal is due by 4 Feb 2027.

Written from GLEIF data using fixed, reviewed sentence templates.

Data-quality notes (AssetCensus analysis)

No data-quality notes for this entity in this data release.

Company details

Legal formGesellschaft mit beschränkter Haftung (GmbH)
private limited company (Germany)
RegisterCommercial Register (Handelsregister) · Register website
Registration numberHRB 12042 PI
Registration authorityLocal Court Pinneberg
JurisdictionGermany
Registered addressTheaterstraße 6, 22880 Wedel, Germany
Categorycompany or other legal entity
Statusactive
Founded (per GLEIF)29 Oct 1971
LEI529900CYHUGUOZJN0I17
LEI statusactive
LEI first issued4 Feb 2014
LEI record last updated7 Dec 2025
Next LEI renewal4 Feb 2027
Corroboration of the LEI recordfully corroborated

Group membership

Medac Gesellschaft für klinische Spezialpräparate m.b.H. this entity
medac pharma production a.s. Czechia

Parent not reported to GLEIF

  • Direct parent: no known person controls the entity, for example because its shareholders are diverse.
  • Ultimate parent: no known person controls the entity, for example because its shareholders are diverse.

Direct subsidiaries (1)